Jordi’s research is focused on, but not restricted, to several aspects of the biosynthesis of isoprenoids; mainly the recently discovered MEP pathway for the production of the universal precursors isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). He is interested in understanding the highly complex regulation of this pathway that currently limits most of the biotechnological approaches to engineer organisms in order to boost the production of isoprenoids of interest. He is working on specific steps of the pathway at the biochemical level but also developing a mass spectrometry screening system to generate a complete metabolic regulatory map of the whole pathway. A complete understanding of the regulatory constraints will lead to more successful and rational metabolic designs to reach the still unaffordable theoretical maximum yield of the pathway. He is also working on new strategies to overcome those constrains and implement them on different metabolic and synthetic strategies to produce industrially-relevant isoprenoids using organisms like E. coli, cyanobacteria, yeast and plants.